XML 37 R30.htm IDEA: XBRL DOCUMENT v3.24.3

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2023

BioFlex And NTM Acquisition

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	2,870
Accounts receivable			1,408
Inventory			741
Prepaid expenses and other current assets			126
Property and equipment			34
Operating lease right of use asset			1,034
Customer relationships			13,240
Developed technology			3,540
Trademark and tradename			310
Non-competition agreements			60
Goodwill			9,834
Long term deferred tax asset			81
Accounts payable			(224	)
Accrued liabilities			(450	)
Operating lease liability			(1,030	)
Operating lease liability, long-term			(3	)
Fair value of net assets acquired		$	31,571

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the NTM Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		10 years		$	13,240
Developed technology		11 years			3,540
Trademark and tradename		15 years			310
Non-competition agreements		3 years			60
				$	17,150

Avitide, Inc.

Schedule of Business Combination Consideration Transferred

Total consideration transferred is as follows (amounts in thousands):

Cash consideration		$	74,962
Equity consideration			82,968
Contingent consideration - earnout			88,373
Fair value of net assets acquired		$	246,303

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	572
Accounts receivable			228
Inventory			332
Prepaid expenses and other current assets			114
Property and equipment			1,862
Operating lease right of use asset			3,648
Customer relationships			24,580
Developed technology			20,650
Trademark and tradename			1,210
Non-competition agreements			210
Goodwill			197,476
Long term deferred tax asset			1,525
Accounts payable			(215	)
Accrued liabilities			(2,183	)
Operating lease liability			(698	)
Operating lease liability, long-term			(2,950	)
Other liabilities			(58	)
Fair value of net assets acquired		$	246,303

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Avitide Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		13 years		$	24,580
Developed technology		15 years			20,650
Trademark and tradename		18 years			1,210
Non-competition agreements		3 years			210
				$	46,650

Polymem S.A.

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and final allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	353
Net working capital (excluding cash and inventory      step-up)			414
Inventory step-up			543
Operating lease right of use assets			1,424
Property and equipment			3,145
Other assets			41
Developed technology			8,274
Trademark and tradenames			510
Non-compete agreements			312
Goodwill			35,680
Operating lease liability			(1,253	)
Long term deferred tax liability			(2,327	)
Other long-term liabilities			(143	)
Fair value of net assets acquired		$	46,973

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Polymem Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Developed technology		13 years		$	8,274
Trademark and tradename		14 years			510
Non-competition agreements		5 years			312
				$	9,096

Metenova Holding AB

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	5,768
Accounts receivable			3,730
Inventory			4,421
Prepaid expenses and other current assets			470
Property and equipment			433
Operating lease right of use asset			615
Customer relationships			12,659
Developed technology			44,377
Trademark and tradename			939
Non-competition agreements			787
Goodwill			115,778
Accounts payable			(1,432	)
Accrued liabilities			(2,934	)
Operating lease liability			(275	)
Deferred tax liability, long-term			(12,481	)
Operating lease liability, long-term			(255	)
Fair value of net assets acquired		$	172,600

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Metenova Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		15 years		$	12,659
Developed technology		15 years			44,377
Trademark and tradename		15 years			939
Non-competition agreements		2 years			787
				$	58,762

FlexBiosys, Inc.

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	1,090
Accounts receivable			683
Inventory			667
Prepaid expenses and other current assets			35
Property and equipment			12,034
Operating lease right of use asset			3,537
Customer relationships			2,530
Developed technology			9,860
Trademark and tradename			30
Non-competition agreements			220
Goodwill			14,321
Other long-term assets			10
Accounts payable			(136	)
Accrued liabilities			(314	)
Operating lease liability			(39	)
Operating lease liability, long-term			(3,498	)
Fair value of net assets acquired		$	41,030

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the FlexBiosys Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		12 years		$	2,530
Developed technology		16 years			9,860
Trademark and tradename		4 years			30
Non-competition agreements		5 years			220
				$	12,640

X

- Definition

Tabular disclosure of business combination consideration transferred.

+ References

No definition available.

+ Details

Name:	rgen_ScheduleOfBusinessCombinationConsiderationTransferredTableTextBlock
Namespace Prefix:	rgen_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-1

+ Details

Name:	us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Paragraph 1
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_BioflexAndNtmAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_AvitideIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_PolymemSAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_MetenovaHoldingAbMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_FlexbiosysIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: